ArticleMetabolites2021

Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach.

Anaïs Draguet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.